Literature DB >> 23504094

[Is there a connection between intraocular pressure and blood pressure? Results of the Gutenberg Health Study and review of the current study situation].

R Höhn1, A Mirshahi, I Zwiener, D Laubert-Reh, N Pfeiffer.   

Abstract

Intraocular pressure (IOD) is the most important risk factor for the occurrence and progression of glaucoma because it is the only measurable risk factor. There is a positive connection between IOD and both systolic and diastolic blood pressure. The clinical relevance is, however, limited because the moderate alterations in IOD are less than the known measurement error and daily physiological oscillation.

Entities:  

Mesh:

Year:  2013        PMID: 23504094     DOI: 10.1007/s00347-013-2796-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  31 in total

1.  Normal intraocular pressure in man.

Authors:  X D Martin
Journal:  Ophthalmologica       Date:  1992       Impact factor: 3.250

2.  Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study.

Authors:  B E K Klein; R Klein; M D Knudtson
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

3.  Intraocular pressure correlated with arterial blood pressure: the beijing eye study.

Authors:  Liang Xu; Han Wang; Yaxing Wang; Jost B Jonas
Journal:  Am J Ophthalmol       Date:  2007-09       Impact factor: 5.258

Review 4.  Blood pressure and glaucoma.

Authors:  V P Costa; E S Arcieri; A Harris
Journal:  Br J Ophthalmol       Date:  2009-03-30       Impact factor: 4.638

5.  Central corneal thickness, radius of the corneal curvature and intraocular pressure in normal subjects using non-contact techniques: Reykjavik Eye Study.

Authors:  Thor Eysteinsson; Fridbert Jonasson; Hiroshi Sasaki; Arsaell Arnarsson; Thordur Sverrisson; Kazuyuki Sasaki; Einar Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2002-02

6.  Intraocular pressure and related systemic and ocular biometric factors in a population-based study in Japan: the Kumejima study.

Authors:  Eriko Tomoyose; Akiko Higa; Hiroshi Sakai; Shoichi Sawaguchi; Aiko Iwase; Atsuo Tomidokoro; Shiro Amano; Makoto Araie
Journal:  Am J Ophthalmol       Date:  2010-06-08       Impact factor: 5.258

Review 7.  Sources of error with use of Goldmann-type tonometers.

Authors:  M M Whitacre; R Stein
Journal:  Surv Ophthalmol       Date:  1993 Jul-Aug       Impact factor: 6.048

8.  An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen.

Authors:  S J Sramek; I H Wallow; D A Tewksbury; C R Brandt; G L Poulsen
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-04       Impact factor: 4.799

9.  Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients.

Authors:  Felipe A Medeiros; Alexandre Pinheiro; Frederico C Moura; Bruno C Leal; Remo Susanna
Journal:  J Ocul Pharmacol Ther       Date:  2002-12       Impact factor: 2.671

10.  Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pagar Study.

Authors:  Paul J Foster; David Machin; Tien-Yin Wong; Tze-Pin Ng; Jim F Kirwan; Gordon J Johnson; Peng T Khaw; Steve K L Seah
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

View more
  3 in total

1.  The Prevalence of Glaucoma in Young People.

Authors:  Susanne Marx-Gross; Dagmar Laubert-Reh; Astrid Schneider; René Höhn; Alireza Mirshahi; Thomas Münzel; Philipp S Wild; Manfred E Beutel; Maria Blettner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2017-03-24       Impact factor: 5.594

2.  [Ophthalmological aspects of the Gutenberg Health Study (GHS): an interdisciplinary prospective population-based cohort study].

Authors:  A Mirshahi; K A Ponto; R Höhn; P S Wild; N Pfeiffer
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

3.  [Study of health in Pomerania (SHIP-Trend): : Important aspects for healthcare research in ophthalmology].

Authors:  C Jürgens; H Völzke; F Tost
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.